| Literature DB >> 22151484 |
John Yianni1, Alexander L Green, Emma McIntosh, Richard G Bittar, Carol Joint, Richard Scott, Ralph Gregory, Peter G Bain, Tipu Z Aziz.
Abstract
Objectives. To perform a preliminary cost-utility and cost-benefit of deep brain stimulation (DBS) in the treatment of dystonia, Materials and Methods. We conducted a prospective study of 26 patients undergoing DBS for the treatment of dystonia. We performed a cost-utility analysis using the Euroquol (EQ-5D) questionnaire. A cost-benefit analysis used the willingness-to-pay principle and costs of treatment were calculated retrospectively in order to calculate the cost-benefit. Results. We found that the EQ-5D score improved from 29 to 76.2 points after surgery, an incremental utility of 0.47. There was an overall gain of 0.94 quality-adjusted life-years (QALY) with a cost of £33,980 per QALY. Conclusions. DBS for dystonia, while an expensive treatment, compares favorably to therapies that are commonly used for other conditions.Entities:
Year: 2005 PMID: 22151484 DOI: 10.1111/j.1525-1403.2005.05233.x
Source DB: PubMed Journal: Neuromodulation ISSN: 1094-7159